Key facts
- LipsTech’s last known valuation is $17.6M (Jun 2025).
- It has raised $470K; the latest was Angel (individual) ($470K) in Jun 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for LipsTech
- ·The full record, as it builds
Funding rounds
No funding rounds for LipsTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LipsTech
Developer of biosensing devices designed for personal monitoring of metabolic health indicators. The company combines saliva-based glucose detection, compact reusable hardware, and app-integrated AI coaching, enabling individuals at risk of chronic conditions to track glucose fluctuations, access estimated biomarker trends, and receive personalized lifestyle feedback through discreet and user-friendly technology.
- Sector
- Healthcare
- HQ
- Villejuif, France
- Founded
- 2024
- Employees
- 4
- Website
- lipstech.fr/
- Ownership
- Privately Held (backing)
LipsTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LipsTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LipsTech in its N-PORT filings yet. We sweep new filings monthly.